Compound Detail
CHEMBL4170344
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4170344 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RHFLAYMFDVUEKT-UHFFFAOYSA-N |
1
Targets
3
Activities
2
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
194.6
MW (Da)
2.58
ALogP
3
HBA
1
HBD
52.0
PSA (Ų)
0.76
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 6.3
EC50 1 meas. best 6.6
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Tryptophan 2,3-dioxygenase CHEMBL2140 | EC50 | 6.6 | 6.6 | 250.0 | 1 |
| Tryptophan 2,3-dioxygenase CHEMBL2140 | IC50 | 6.3 | 5.915 | 500.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Tryptophan 2,3-dioxygenase | EC50 | = | 250.0 | nM | 6.6 | Inhibition of TDO2 in human SW48 cells assessed as decrease in conversion of try... | 29795752 |
| Tryptophan 2,3-dioxygenase | IC50 | = | 500.0 | nM | 6.3 | Inhibition of recombinant human TDO2 assessed as decrease in conversion of L-try... | 29795752 |
| Tryptophan 2,3-dioxygenase | IC50 | = | 2940.0 | nM | 5.53 | Competitive inhibition of recombinant human TDO2 assessed as decrease in convers... | 29795752 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 29795752 | 10.1021/acsmedchemlett.7b00427 | Tryptophan 2,3-dioxygenase | 3 |
| 29795752 | 10.1021/acsmedchemlett.7b00427 | SW48 | 1 |
| 29795752 | 10.1021/acsmedchemlett.7b00427 | A 172 | 1 |
Data from ChEMBL 36 via Core Engine